Incidence of haematological malignancies in Kosovo-A post "uranium war" concern.

Tytuł:: Incidence of haematological malignancies in Kosovo-A post "uranium war" concern.
Autorzy:: Latifi-Pupovci H; Department of Physiology and Immunology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo.
Selmonaj M; Department of Physiology and Immunology, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo.
Ahmetaj-Shala B; National Heart and Lung Institute, Imperial College, London, United Kingdom.
Dushi M; Department of Geography, Faculty of Natural Sciences, University of Prishtina, Prishtina, Kosovo.
Grajqevci V; Department of Paediatrics, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo.
Źródło:: PloS one [PLoS One] 2020 May 04; Vol. 15 (5), pp. e0232063. Date of Electronic Publication: 2020 May 04 (Print Publication: 2020).
Typ publikacji:: Historical Article; Journal Article
Język:: English
Imprint Name(s):: Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:: Uranium*
Warfare*/history
Hematologic Neoplasms/*epidemiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Hematologic Neoplasms/history ; History, 20th Century ; History, 21st Century ; Humans ; Incidence ; Infant ; Infant, Newborn ; Kosovo/epidemiology ; Male ; Middle Aged ; Retrospective Studies ; Young Adult
References:: J Radiol Prot. 2008 Sep;28(3):303-25. (PMID: 18714128)
Saudi Med J. 2012 May;33(5):483-8. (PMID: 22588807)
Curr Med Chem. 2018;25(1):49-64. (PMID: 28462701)
Radiat Environ Biophys. 2007 Aug;46(3):221-7. (PMID: 17549506)
Int Arch Occup Environ Health. 2007 Aug;80(8):679-88. (PMID: 17357798)
Cancer Epidemiol. 2014 Aug;38(4):364-8. (PMID: 24813719)
Int J Environ Res Public Health. 2010 Jul;7(7):2828-37. (PMID: 20717542)
J Radioanal Nucl Chem. 2014;299(3):1267-1272. (PMID: 26224958)
Toxicology. 2013 Jul 5;309:81-90. (PMID: 23659960)
Environ Res. 2017 Jul;156:665-673. (PMID: 28472753)
J Environ Radioact. 2003;64(2-3):121-31. (PMID: 12500799)
J Natl Cancer Inst. 2011 May 4;103(9):753-62. (PMID: 21483021)
J Acquir Immune Defic Syndr. 2009 Dec;52(5):611-22. (PMID: 19770804)
Chemosphere. 2004 Sep;56(9):861-5. (PMID: 15261532)
Arh Hig Rada Toksikol. 2005 Sep;56(3):227-32. (PMID: 16180607)
Lancet. 2007 Jul 7;370(9581):59-67. (PMID: 17617273)
Sci Total Environ. 2001 Dec 17;281(1-3):23-35. (PMID: 11778955)
Cancer Epidemiol. 2013 Oct;37(5):550-5. (PMID: 23707157)
Occup Environ Med. 2004 Feb;61(2):171-3. (PMID: 14739385)
J Carcinog. 2008;7:8. (PMID: 19008567)
Health Phys. 2002 Oct;83(4):543-8. (PMID: 12240731)
MMWR Recomm Rep. 2008 Dec 5;57(RR-10):1-12. (PMID: 19052530)
Chemosphere. 2005 Sep;60(9):1246-52. (PMID: 16018895)
BMC Cancer. 2016 Feb 25;16:159. (PMID: 26915519)
J Environ Radioact. 2003;64(2-3):143-54. (PMID: 12500801)
Rev Environ Health. 2007 Jan-Mar;22(1):75-89. (PMID: 17508699)
Chemosphere. 2013 Nov;93(9):2165-70. (PMID: 24070912)
Environ Sci Technol. 2018 Feb 20;52(4):2359-2367. (PMID: 29301089)
Toxicol Ind Health. 2008 Oct;24(9):603-10. (PMID: 19106127)
Sci Total Environ. 2007 Aug 1;381(1-3):77-87. (PMID: 17459457)
Eur J Cancer. 2006 Sep;42(14):2355-8. (PMID: 16857358)
Ann Oncol. 2007 Jan;18 Suppl 1:i3-i8. (PMID: 17311819)
J Environ Radioact. 2017 Jun;172:207-217. (PMID: 28395154)
BMC Cancer. 2014 Jun 14;14:438. (PMID: 24929433)
Environ Int. 2010 May;36(4):352-360. (PMID: 20303178)
Radiat Prot Dosimetry. 2001;97(4):317-20. (PMID: 11878410)
Eur J Public Health. 2010 Jun;20(3):288-92. (PMID: 19897587)
Sci Total Environ. 2005 Jan 20;337(1-3):109-18. (PMID: 15626383)
Br J Cancer. 2011 Nov 22;105(11):1684-92. (PMID: 22045184)
Biochimie. 2009 Oct;91(10):1328-30. (PMID: 19324073)
Ann Oncol. 2013 Nov;24(11):2897-902. (PMID: 24078620)
J Environ Radioact. 2003;64(2-3):93-112. (PMID: 12500797)
Cancer Epidemiol. 2010 Feb;34(1):47-54. (PMID: 20080071)
Substance Nomenclature:: 4OC371KSTK (Uranium)
Entry Date(s):: Date Created: 20200505 Date Completed: 20200727 Latest Revision: 20200727
Update Code:: 20240105
PubMed Central ID:: PMC7197787
DOI:: 10.1371/journal.pone.0232063
PMID:: 32365107
: Czasopismo naukowe

Pełny tekst

Background: During the Kosovo War (1998-99) approximately 31,000 rounds with Depleted Uranium (DU) were fired on 85 targets in Kosovo. The number of haematological malignancies (HM) increased after the war and the concern was the use of DU during the war. The aim of this study was to analyse the incidence rates of HM in Kosovo throughout a 20-year that includes pre- and post- war period (1995-2015); and to examine if there is any association between the use of DU rounds and incidence rates of HM in different regions of Kosovo.
Methods: In this retrospective register-based study, 1,798 new patients diagnosed with leukaemia, Hodgkin lymphoma, non-Hodgkin lymphoma and Multiple myeloma were analysed over a 20 year period. Incidence rates were calculated focusing on specific time periods, regions and age-groups. In addition, the correlation between the use of DU in different regions and their incidence of HM was analysed.
Results: The average annual crude rate of all HM in Kosovo was 5.02 cases per 100,000 persons. Incidence rates of HM in first post-war period (2000-2003) increased by 0.37 cases/100,000 persons (9.51%) compared to the pre-war period (1995-1998) whereas in the last post-war period (2012-2015), incidence of HM increased by 3.19/100,000 persons (82%). Gjakova and Peja, the first and third most exposed regions to DU ordnance ranked first and second in difference in HM. Prishtina, Gjilan and Ferizaj, regions with the least number of rounds/km2, were characterized by a decline of incidence rates.
Conclusions: After the war, the increase in incidence rate of HM was higher in two regions with most DU rounds/km2 expended Despite these findings, this study warrants further investigation and does not lead us to a conclusive finding on the existence of a causal relationship between the use of DU during the war and the rise in incidence of HM in Kosovo.
Competing Interests: The authors have declared that no competing interests exist.

Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Informacja